https://www.selleckchem.com/pr....oducts/atuzabrutinib
To assess the association of severe pulmonary arterial hypertension (PAH) with particulate matter 2.5 μm (PM2.5) and clinical data in patients with systemic autoimmune rheumatic diseases (SARDs). We used the 2003-2017 nationwide data in Taiwan to identify patients with SARDs, including systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, dermatomyositis/polymyositis and primary Sjögren's syndrome. We identified 479 cases with severe PAH and selected controls matched (14) for age, sex, and index-year. We used